Generics and biosimilars are crucial to healthcare worldwide, but there are challenges in getting these medicine to patients.

EMJ spoke to Christopher Chapple about his role as Secretary General of the European Association of Urology (EAU)…

The challenges faced by the transgender community are vast, but pharma has the power to drive better health equity. Read more.

Infographic: Boehringer Ingelheim | Improve, Protect, Prevent. The publication of this infographic has been funded by Boehringer Ingelheim.

Implementation science and community-engaged approaches can address cancer inequities by improving the delivery, uptake, and effective expansion of evidence-based cancer care in real-world resource-limited settings.

THIS YEAR’S European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress was the 38th, and the first ever hybrid congress organised by ECTRIMS. The congress, which is the world’s largest for research into the pathogenesis, diagnosis, and treatment in multiple sclerosis (MS) and related neurological disorders, is held in collaboration with Rehabilitation in Multiple Sclerosis (RIMS).

PROGRESSIVE multiple sclerosis (MS) posed an important topic of discussion at the 38th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, held in Amsterdam, the Netherlands, between 26th–28th October 2022. Throughout the engaging session on progressive MS, chaired by Kathy Smith, National Multiple Sclerosis Society, New York, USA, and Jan Meilof, University of Groningen, the Netherlands, key learning and focus points to consider for the future of clinical trials and treatments were summarised and spotlighted.